Pancreatic cancer
hidePancreatic cancer is a malignant neoplasm of the pancreas. Each year in the United States, about 42,470 individuals are diagnosed with this condition and 35,240 die from the disease. The prognosis is generally poor; less than 5 percent of those diagnosed are still alive five years after diagnosis. Complete remission is still extremely rare. About 95% of exocrine pancreatic cancers are adenocarcinomas (M8140/3). The remaining 5% include adenosquamous carcinomas, squamous cell carcinomas, and giant cell carcinomas. Exocrine pancreatic cancers are far more common than endocrine pancreatic cancers (islet cell carcinomas), which make up about 1% of total cases.
For more information about Pancreatic cancer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with pancreatic cancer
Is type 2 diabetes mellitus a risk factor for gallbladder, biliary and pancreatic cancer?
Nov 19, 2009 |
not rated yet |
0
There are minimal data assessing the relationship between diabetes with gallbladder, biliary and pancreatic cancer. Recent small studies have suggested an elevated risk of pancreatic cancer only in patients with diabetes ...
Discovery offers potential new pancreatic cancer treatment
Nov 02, 2009 |
3 / 5 (1) |
1
Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer. New research to be presented in November at the American Association of Pharmaceutical Scientists ...
Possible origins of pancreatic cancer revealed
Nov 02, 2009 |
3 / 5 (1) |
0
(PhysOrg.com) -- MIT cancer biologists have identified a subpopulation of cells that can give rise to pancreatic cancer. They also found that tumors can form in other, more mature pancreatic cell types, but ...
Hepatitis B does not increase risk for pancreatic cancer
Nov 01, 2009 |
not rated yet |
0
A Henry Ford Hospital study found that hepatitis B does not increase the risk for pancreatic cancer - and that only age is a contributing factor.
Circulating Mesothelin Serves as a Marker of Pancreatic Cancer
Oct 22, 2009 |
not rated yet |
0
(PhysOrg.com) -- Researchers have expanded on previous studies, and there may be a new weapon in the arsenal for immune-based strategies in treating pancreatic cancer - mesothelin protein. Findings also showed that circulating ...
Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy
Sep 24, 2009 |
4 / 5 (1) |
0
For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug ...
Endothelin-1 inhibitors in chronic pancreatitis
Sep 17, 2009 |
not rated yet |
0
Fibrosis is a key feature of chronic pancreatitis and pancreatic cancer. The extensive deposition of extracellular matrix proteins fosters the development of an exocrine and endocrine organ insufficiency, and accelerates ...
Malignant signature may help identify patients likely to respond to therapy
Sep 06, 2009 |
5 / 5 (1) |
1
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. ...
Pancreatic cancer affects blacks at higher rates
Sep 01, 2009 |
5 / 5 (1) |
0
Regardless of risk factors linked to pancreatic cancer, such as smoking and body mass index (BMI), blacks experienced higher rates of pancreatic cancer death than whites.
Does the distance a patient has to travel affect where they choose to get their care?
Aug 31, 2009 |
not rated yet |
0
Do patients choose where to get their care based on how long it takes to them to get there? Researchers at Fox Chase Cancer Center have recently documented a growing trend in the centralization of cancer surgery—more patients ...
New initiative to develop modeling tools for disease and complex systems
Technology / Computer Sciences
Aug 19, 2009 |
2 / 5 (1) |
0
A multidisciplinary team led by Carnegie Mellon University computer scientist Edmund M. Clarke has received a five-year, $10 million grant from the National Science Foundation's Expeditions in Computing program to create ...
Prion protein identified as a novel early pancreatic cancer biomarker
Aug 17, 2009 |
5 / 5 (1) |
0
Mad cow disease is caused by the accumulation of an abnormal protein, the prion, in the brain of an affected patient. Outside of the brain, very little is known about prions. Case Western Reserve University School of Medicine, ...
New study expands the list of hazardous chemicals in smokeless tobacco
Aug 16, 2009 |
not rated yet |
1
Attention all smokeless tobacco users! It's time to banish the comforting notion that snuff and chewing tobacco are safe because they don't burn and produce inhalable smoke like cigarettes. A study that looked ...
New tool may help with early detection of deadly pancreatic cancer
Aug 03, 2009 |
not rated yet |
0
A new diagnostic tool developed by Van Andel Research Institute (VARI) scientists has shown promising results when used with patients of pancreatic cancer, one of the deadliest forms of cancer due to the difficulty of diagnosing ...
Common diabetic therapy reduces risk of pancreatic cancer, study finds
Aug 01, 2009 |
5 / 5 (4) |
0
Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual's risk of developing pancreatic cancer by 62 percent, according to research from The University of Texas M. D. Anderson ...
